RPB News

Glaucoma may affect patients’ travel habits and health

For more on the impact of vision loss, read RPB's recent newsletter. RPB-supported research shows that patients with visual field loss from glaucoma travel less than those with normal vision,curtail...

Glaucoma Medication Delivered By Contact Lens

RPB-supported researchers have demonstrated that a new type of contact lens can deliver a therapeutic amount of a glaucoma drug every day for a month. The breakthrough, which has been pursued for decades, may...

Older Adults Experience More Vision Difficulties at Home

Adults have better vision in clinics rather than at home, due to poor home lighting, according to an RPB-supported study by Anjali M. Bhorade, M.D., MSCI, of the Washington University School of Medicine, St. Louis,...

Simple Urine Test Could Diagnose Retinitis Pigmentosa

Research led by RPB-supported physician-scientists has produced a breakthrough discovery in diagnosing a blinding disease that affects about 1 in 4,000 people in the United States.Read the full story.

A Promising New Treatment for Macular Degeneration

RPB-supported researchers have published new findings indicating they are on the verge of developing a better treatment than the anti-VEGF injections currently used for macular degeneration. In studies, a class of...

RPB Awards Lab Grant to University of Florida

Research to Prevent Blindness (RPB) has awarded a prestigious, one-time laboratory grant of $600,000 to the Department of Ophthalmology at the University of Florida, College of Medicine. The newly created...

RPB Researcher Pursues Clues to Rare Eye Disease that Could Help Millions

Screenshot from the video "A Blind Man's Journey"

Watch The Video

RPB Career Development Awardee Vinit Mahajan, MD, PhD is studying members of an Iowa family who are facing varying stages of blindness related to a rare genetic disorder known as autosomal dominant neovascular...

Researchers Discover New Relationship Between Rods and Cones

Rods and cones, the major light receptor cells in the mammalian eye, are densely packed across the retina where they convert light into the image-forming signals that allow the brain to create vision. Rods...

RPB and OCT Research

In addition to Dr. Wang’s work, RPB has funded many important OCT-related research projects since 2004: Correlation of specific gene mutation in Stargardt’s disease with OCT-identified...

RPB Funding Yields Big Gains

Crowds at the ARVO 2013 meeting of nearly 12,000 vision scientists and physicians from around the world heard and saw the hundreds of ways that funding from Research to Prevent Blindness (RPB) is yielding major...

Bionic Retina Soon Available In the U.S.

Screenshot of video about the Arugus II Retinal Prosthesis System

Watch The Video

The first implantable device to treat advanced retinitis pigmentosa, the Argus II Retinal Prosthesis System, will be available at several clinical centers across the U.S. later this year. The system took more...

Coming Soon, A Blood Test to Predict When Dry AMD Becomes Wet?

RPB-supported researchers have published a study that is the foundation for a promising new blood test to detect the earliest progression of macular degeneration to its more serious form, creating an opportunity for...

Research to Prevent Blindness, Inc. Names Brian Hofland as President

New York, NY, January 7, 2013 --Research to Prevent Blindness, Inc. (RPB) today named Brian F. Hofland, Ph.D. as the sixth president in its 52-year history. RPB is the leading nonprofit source of...